0000899243-19-004939.txt : 20190226
0000899243-19-004939.hdr.sgml : 20190226
20190226214756
ACCESSION NUMBER: 0000899243-19-004939
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190222
FILED AS OF DATE: 20190226
DATE AS OF CHANGE: 20190226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JOHNSON JOHN
CENTRAL INDEX KEY: 0001410781
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35405
FILM NUMBER: 19635661
MAIL ADDRESS:
STREET 1: DENDREON CORPORATION
STREET 2: 1301 2ND AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98101
FORMER NAME:
FORMER CONFORMED NAME: Johnson John H
DATE OF NAME CHANGE: 20070827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MELINTA THERAPEUTICS, INC. /NEW/
CENTRAL INDEX KEY: 0001461993
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454440364
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 GEORGE STREET
STREET 2: SUITE 301
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 312 767 0291
MAIL ADDRESS:
STREET 1: 300 GEORGE STREET
STREET 2: SUITE 301
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
FORMER COMPANY:
FORMER CONFORMED NAME: CEMPRA, INC.
DATE OF NAME CHANGE: 20120203
FORMER COMPANY:
FORMER CONFORMED NAME: Cempra Holdings, LLC
DATE OF NAME CHANGE: 20090414
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-22
0
0001461993
MELINTA THERAPEUTICS, INC. /NEW/
MLNT
0001410781
JOHNSON JOHN
C/O MELINTA THERAPEUTICS, INC.
300 GEORGE STREET, SUITE 301
NEW HAVEN
CT
06511
1
1
0
0
Chief Executive Officer
Restricted Stock Units
0.00
2019-02-22
4
A
0
400000
0.00
A
Common Stock
400000
400000
D
The restricted stock units will vest in equal quarterly installments over the two year period following February 22, 2019, subject to Mr. Johnson's continued service with the Issuer through the applicable vesting date.
All share numbers in this Form 4 reflect the 1-for-5 reverse stock split which became effective as of 5 p.m. February 21, 2019.
/s/ John Johnson
2019-02-22